Insulet (PODD) Revenue (2016 - 2025)
Historic Revenue for Insulet (PODD) over the last 17 years, with Q3 2025 value amounting to $706.3 million.
- Insulet's Revenue rose 2985.84% to $706.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 billion, marking a year-over-year increase of 2711.83%. This contributed to the annual value of $2.1 billion for FY2024, which is 2206.71% up from last year.
- Per Insulet's latest filing, its Revenue stood at $706.3 million for Q3 2025, which was up 2985.84% from $649.1 million recorded in Q2 2025.
- In the past 5 years, Insulet's Revenue registered a high of $706.3 million during Q3 2025, and its lowest value of $252.3 million during Q1 2021.
- Its 5-year average for Revenue is $426.2 million, with a median of $396.5 million in 2023.
- In the last 5 years, Insulet's Revenue soared by 1375.38% in 2022 and then skyrocketed by 3789.56% in 2023.
- Quarter analysis of 5 years shows Insulet's Revenue stood at $307.7 million in 2021, then increased by 20.15% to $369.7 million in 2022, then surged by 37.9% to $509.8 million in 2023, then increased by 17.2% to $597.5 million in 2024, then increased by 18.21% to $706.3 million in 2025.
- Its Revenue stands at $706.3 million for Q3 2025, versus $649.1 million for Q2 2025 and $569.0 million for Q1 2025.